Palomares' Lab at SEI2026 in Córdoba!! Alba Angelina ("Peanut allergoid-mannan conjugates for food allergy IT"), Leticia Martín ("Tumoral Ca10 and Tregs), Natalia Cuervo ("Cannabinoids in keratinocytes"), Isabel Peñalver ("TSLP-induced metabolic rewiring in cDC2s"). Well done!!

It was a great pleasure to contribute to the 20th anniversary of the WIRM! We presented our data on MV130 preventing allergic eosinophilic asthma, and cannabinoids generating tolerogenic extracellular vesicles. Congratulations to Ángel Maldonado on receiving his award!

We welcome Prof. Palomares as new Associate Editor. Oscar Palomares is a professor and head of the research group “Vaccines and Dendritic cells” in the Biochemistry and Molecular Biology Department, Chemistry School, at Complutense University of Madrid. The major focus of Dr. Palomares’ research group is the study of the role of human dendritic cells, epithelial cells and other hematopoietic and non-hematopoietic cells in the context of immune-mediated inflammatory diseases, including allergy, asthma, infections and cancer, to identify potential novel biomarkers and therapeutic targets for such diseases. The group is also interested in the understanding of the MoA of biologicals, next-generation vaccines for allergen-specific immunotherapy and trained immunity-based vaccines for infectious and allergic diseases. Professor Palomares’ research has so far generated 170 publications in world leading, peer-reviewed international journals and 9 book chapters. He has been invited to participate in more than 120 conferences at national and international meetings and has received 10 awards. He has undertaken the role of Chairperson on more than 100 occasions during scientific sessions and has been involved in the organization of 50 international congresses. Prof. Palomares is currently member of the Board-of-Officers (Vice-President for Science) of the European Academy of Allergy and Clinical Immunology (EAACI) and Editor-in-Chief of EAACI Knowledge Hub. You can find a biographical description of other Allergy Editors at the “Who are We” page on our website! journalallergy.com/Who-are-W… #Allergy_journal @Palomares_Lab

Congratulations to Prof. Dr. Palomares receiving Allergy’s Top Reviewer Award. journalallergy.com #Topreviewer #Allergy_journal @Palomares_Lab

👇No os perdáis hoy, a las 19:00h a @Palomares_Lab hablará en Allergotrends (@inmunotek ) sobre los"Avances en inmunidad innata entrenada en inmunoterapia específica de alérgeno: Vacunas bacterianas para la prevención y tratamiento del asma alérgica". eventos.quodem.com/allergotr…

Palomares’ Lab members at an exciting meeting on the challenges and opportunities in immunology to fight antimicrobial resistance at Hospital Clínico San Carlos. Congratulations to the organizers and all the speakers for the excellent talks and discussions! Truly enjoyable!

🎉 ¡Enhorabuena a nuestros compañeros del BBM UCM por figurar en el Stanford–Elsevier World’s Top 2% Scientists 2025! 🌍 Marco Cordani, Jesús Fernández, Óscar Palomares, Jesús Perez Gil, Manuel Guzmán, Javier Fernández Ruiz y Guillermo Velasco 👏🔬 #UCM #Ciencia

Durante décadas, el concepto de “células supresoras”o "reguladoras"fue controvertido. Muchos investigadores desconfiaban de la existencia de células cuya función específica principal fuera suprimir respuestas inmunes. 35 años después, sus descubridores reciben el premio Nobel.

💉En @inmunotek se está investigando la vacuna MV130, una vacuna para prevenir el desarrollo del asma. 🗣️Nos lo cuentan @Palomares_Lab investigador en @unicomplutense y Laura Conejero, investigadora en inmunología. 🔗 A las 10.30 horas en @ree_rne rtve.es/play/radio/radio-ext…

Entrevista de Maria López a Oscar Palomares:”Una puerta abierta a la vacuna del asma” en el programa Buenos Dias Madrid de TeleMadrid drive.google.com/file/d/16wj…

Muy contentos de que nuestros hallazgos con la vacuna bacteriana MV130 de Inmunotek pueda mejorar la vida de los pacientes asmáticos! Seguimos trabajando para ello!! elconfidencial.com/salud/202…

Muy contentos de que nuestros hallazgos con la vacuna bacteriana MV130 de Inmunotek pueda mejorar la vida de los pacientes asmáticos! Seguimos trabajando para ello!! telemadrid.es/noticias/madri…

Una #vacuna española abre una nueva vía en la prevención del #asma La investigación dirigida por @Palomares_Lab en colaboración con Laura Conejero y José Luis Subiza (@inmunotek), demuestra por primera vez que la #vacunaMV130 previene el desarrollo de asma alérgica eosinofílica en modelos animales, con un efecto protector que se mantiene hasta nueve semanas después de finalizar el tratamiento. @ucc_complutense

Palomares_Lab at amazing EAACI 2025 congress in Glasgow! Congrats to Dr. Benito-Villalvilla for her award on IgE-pDCs-Treg axis in Crohn’s Disease talk and Dr. Angelina, Natalia Cuervo and Isabel Peñalver for great presentations on endogeneous receptors cannabinoids and MV130!

A great honor to recieve the AeDA Immunotherapy Award 2025 and give a talk in the plenary session in Allergologie im Kloster 2025 congress. This is dedicated to all members of the "Vaccines and Dendritic Cells Lab" at UCM and to all our collaborators & friends during these years!

Happy to share our last findings published in @jacionline in collaboration with @SIAF_UZH. We keep working on cannabinoids & epithelial cells! Cannabinoid WIN55,212-2 restores bronchial epithelium by regulating oxidative stress and STAT6 phosphorylation pubmed.ncbi.nlm.nih.gov/4038…